Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T15:51:17.669Z Has data issue: false hasContentIssue false
  • English
  • Français

Bottom up Nano-particle Formation via Controlled Crystallization and Chemical Reactions

Published online by Cambridge University Press:  30 August 2011

Thomai Panagiotou  and
Robert J. Fisher
Thomai Panagiotou
Affiliation:
Microfluidics International Corporation, P.O. Box 9101, 30 Ossipee Newton, MA 02464, USA
Robert J. Fisher
Affiliation:
Dept. of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
Get access

Abstract

Many manufacturing techniques to produce nano-materials via a “bottom-up” approach are currently being developed and evaluated. The PureNanoTM platform technology developed by Microfluidics International Corporation (MFIC) has proven to be both an effective and energy efficient method to produce nano-scale entities including emulsions in addition to suspensions. This nano-manufacturing platform utilizes crystallization, precipitation and chemical reaction methods that produce nano-particles with specified size distributions and a desired morphology. The solids formed can be either amorphous or crystalline, which may exist in numerous polymorphs. In many cases the ability to obtain a specific composition (single species or mixture) is possible via careful selection and implementation of key processing conditions. The methods are based on controlling the local degree of super-saturation (SS) and/or stoichiometry during their formation and subsequent configuration and growth, when appropriate. To accomplish this, operational strategies and innovative processing techniques are coupled with qualitative insight into the basic mechanisms involved with these processes. Validation of the technology at the bench scale for crystallization, emulsions/cargo loading, and multi-phase reactions (interfacial and homogeneous) provided the justification to develop commercial scale systems. Examples are given here for crystallization of drugs for the pharmaceutical industry, a catalyst formed by deposition of metallic crystals on a carbon substrate, production of fine chemicals via emulsion formation for multi-phase reactions, and a homogeneous substitution reaction forming an insoluble product. Nano-materials with median particle size as low as 50 nm were produced. With respect to the drug particles, they were highly crystalline, of a single polymorph and pure. In all cases, results indicate both process performance enhancement and product quality/functionality improvements compared to materials produced with conventional methods, with at least 1-2 order of magnitude increases in surface/interfacial area and reduced energy needs. Furthermore, the technology is suitable for current Good Manufacturing Practices (cGMP) manufacturing.

Keywords

chemical reactioncrystallinenanostructure
Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 1353: Symposium HH – The Business of Nanotechnology III , 2011 , mrss11-1353-hh04-03
Copyright
Copyright © Materials Research Society 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Mahajan, A. and Kirwan, D., “Micromixing Effects in a Two-Impinging-Jets Precipitator”, AIChE Journal, 42(7) 1801–1814, 1996.10.1002/aic.690420702Google Scholar
2. Johnson, B. and Prud’homme, R., “Chemical Processing and Micromixing in Confined Impinging Jets” AIChE Journal, 49(9), 2264–2282, 2003 10.1002/aic.690490905Google Scholar
3. Costello, R., “Tiny Reactors Aim for Big Role”, Chem. Proc., 12, 2006.Google Scholar
4. Panagiotou, T., Mesite, S., Fisher, R. J., “Production of Norfloxacin Nanosuspensions Using Microfluidics Reaction Technology (MRT) through Solvent/Antisolvent Crystallization”, Industrial and Engineering Chemistry Research, 48, (2009).10.1021/ie800955tGoogle Scholar
5. Kipp, J., Wong, J., Doty, M., Rebbeck, C., “ Microprecipitation Method for Preparing Submicrometer Suspensions”, U.S. Patent 6,869,617 (2001).Google Scholar
6. Panagiotou, T., Fisher, R., “Nano-particle Formation via Controlled Crystallization: A “Bottom-up” Approach”, Chem. Eng. Prog 104, 33(2008).Google Scholar
7. Panagiotou, T. and Fisher, R. J., “Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones”, J. Drug Delivery, Vol. 2011, Article ID 902403 (2011).10.1155/2011/902403Google Scholar
8. Panagiotou, T., Mesite, S., Bernard, M., Chomistek, K., Fisher, R., “Production of Polymer Nanosuspensions Using Microfluidizer Processor Based Technologies”, Tech. Proc. 2007 NSTI Nanotechnol. Conf. Trade Show, 1 (2008).Google Scholar
9. Baldyga, J.; Bourne, J. Turbulent Mixing and Chemical Reactions; John Wiley & Sons, Ltd.: New York, 1999.Google Scholar
10. Deen, W. M., “Analysis of Transport Phenomena”, Oxford University Press, Inc., New York (1998)Google Scholar
11. Brennen, C. E., “Cavitation and Bubble Dynamics”, Oxford University Press, Inc., London (1995).Google Scholar
12. Myerson, A., Handbook of Industrial Crystallization, 2nd Edition – Butterworth-Heinemann, 2002 Google Scholar
13. Rabinow, B., “Pharmacokinetics of Nanosuspensions”, Nanotechnology for Drug Delivery Conference, Philadelphia, PA (2005).Google Scholar
14. Rabinow, B.,“Nanosuspensions in Drug Delivery”, Nat. Rev. Drug Discovery, 3, 785 (2004).10.1038/nrd1494Google Scholar
15. Merisko-Liversidge, E., Liversidge, G., Cooper, E. “NanosizingA Formulation Approach for Poorly-Water-Soluble Compounds”, Eur. J. Pharm. Sci. 18, 113 (2003).10.1016/S0928-0987(02)00251-8Google Scholar
16. Liversidge, G., “Controlled Release and Nanotechnologies: Recent Advances and Future Opportunities”, Drug Development and Delivery, 11:1 (2011).Google Scholar
17. Panagiotou, T., Mesite, S., Fisher, R., “Production of Crystalline Nanoparticles Using Microfluidics Reaction Technology”, 17th International Symposium on Industrial Crystallization Maastricht(the Netherlands) (2008).Google Scholar
18. Zhong, J., Shen, Z., Yang, Y., Chen, J., “ Preparation and Characterization of Uniform Nanosized Cephradine by Combination of Reactive Precipitation and Liquid Anti-Solvent Precipitation Under High Gravity Environment”, Int. J. Pharm., 301 (2005).10.1016/j.ijpharm.2005.06.005Google Scholar
19. Midler, J., “Crystallization Method to Improve Crystal Structure and Size”, U.S. Patent 5,314,506 (1994).Google Scholar
20. Kumar, R., Tyagi, R., Parmar, V.S., Watterson, A.C., Kumar, J., Zhou, J., Hardiman, M., Fisher, R., Colton, C.K., “Perfluorinated Amphiphilic Polymers as Nano Probes for Imaging and Delivery of Therapeutics for Cancer”, Polymer Preprints, 45:2 (2005).Google Scholar
21. Miller, M.T., “ In Vitro Evaluation of Cytotoxicity and Cellular Uptake of Alternating Copolymers for use as Drug Delivery Vehicles”, Ph.D. Dissertation, Department of Chemical Engineering, Massachusetts Institute of Technology, (2009).Google Scholar
22. Stephan, M. T., Moon, J.J., Um, S. H, Bershteyn, A., Irvine, D. J. ,“Therapeutic Cell Engineering with Surface-Conjugated Synthetic Nano-particles”, Nature Medicine, Aug. 15, (2010).10.1038/nm.2198Google Scholar
23. Swiston, A., Cheng, C., Um, S., Irvine, D., Cohen, R., Rubner, M., “Surface Functionalization of Living Cells with Multilayer Patches”, Nano Lett, 8, (2008).10.1021/nl802404hGoogle Scholar
24. Fisher, R.J., Peattie, R.A., “Controlling Tissue MicroEnvironments: Biomimetics, Transport Phenomena, and Reacting Systems”, Adv. Biochem. Engg/Biotech. , 103, (2007).Google Scholar
25. Sokolnicki, A.M., Fisher, R.J., Kaplan, D.L., Harrah, T.P., “Permeability Studies with Bacterial Cellulose Membranes”, J.Memb.Sci., 6793, (2005).Google Scholar
26. Christodoulakis, K.E., Vamvakaki, M., “ Amphoteric Core-Shell Microgels: Contraphilic Two Compartment Colloidal Particles” Langmuir, 26, (2010).10.1021/la902231bGoogle Scholar
27. Stratakis, E., Mateescu, A., Barberoglou, M., Vamvakaki, M., Fotakis, C., Anastasiadis, S.H.,“ From Superhydrophobicity and Water Repellency to Superhydrophilicity: Smart Polymer-Functionalized Surfaces” Chem. Comm., 46, (2010).10.1039/c003294hGoogle Scholar
28. Peattie, R.A., Pike, D.B., Yu, B., Cai, S., Shu, X.Z., Prestwich, G.D., Firpo, M.A., Fisher, R.J., “Effect of Gelatin on Heparin Regulation of Cytokine Release from Hyaluronan-based Hydrogels”, J. Drug Delivery, 15, (2008).Google Scholar
29. Peattie, R.A., Nayate, A.P., Firpo, M.A., Shelby, J., Fisher, R.J., Prestwich, G.D., “Stimulation of In-Vivo Angiogenesis by Cytokine Loaded Hyaluronic Acid Hydrogel Implants”, Biomaterials, 25, (2004).10.1016/j.biomaterials.2003.09.054Google Scholar
30. Pike, D.B., Cai, S., Pomraning, K.R., Firpo, M.A., Fisher, R.J., Shu, X.Z., Prestwich, G.D., Peattie, R.A., “Heparin-Regulated Release of Growth Factors In Vitro and Angiogenic Response In Vivo to Implanted Hyaluronan Hydrogels Containing VEGF and bFGF”, Biomaterials 27, (2006).10.1016/j.biomaterials.2006.05.018Google Scholar
31. Peattie, R.A., Rieke, E.R., Hewett, E.M., Fisher, R.J., Shu, X.Z., Prestwich, G.D., “Dual Growth Factor-induced Angiogenesis In-Vivo using Hyaluronan Hydrogel Implants”, Biomaterials, 27, (2006).10.1016/j.biomaterials.2005.09.035Google Scholar
32. Pardridge, W.M., “Drug targeting to the brain”, Pharm. Res. 24, (2007).Google Scholar
33. Lv, Y., Cheung, N.K., Fu, B.M., “A Pharmacokinetic Model for Radioimmunotherapy Delivered through Cerebrospinal Fluid for the Treatment of Leptomeningeal Metastases”., J. of Nuclear Med., 50, 8 (2009).10.2967/jnumed.108.060798Google Scholar
34. Li, G., Yuan, W., BM, W.. Fu, B.M., (2010) “A Model for Water and Solute Transport across the Blood-Brain Barrier”. J. of Biomechanics, (in press), (2011).Google Scholar
35. Pardridge, W.M., “Molecular Trojan horses for blood-brain barrier drug delivery”, Curr. Opin. in Pharm., 6, 5, (2006).10.1016/j.coph.2006.06.001Google Scholar
36. Miller, G., “Drug targeting. Breaking down barriers”, Science, 297, 5584, (2002).10.1126/science.297.5584.1116Google Scholar
37. Gosk, S., Vermehren, C., Storm, G., Moos, T., (2004) “Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion”, J Cereb Blood Flow Metab., 24, 11, (2004).10.1097/01.WCB.0000135592.28823.47Google Scholar
38. Johnson, A.S., Fisher, R.J., Weir, G.C., Colton, C.K., “Oxygen Consumption and Diffusion in Assemblages of Respiring Spheres: Performance Enhancement of a Bio-artificial Pancreas”, Chem. Eng. Sci, 64, 22, (2009).10.1016/j.ces.2009.06.028Google Scholar
39. Douglas, K.L., Carrigan, S.D., Tabrizian, M., “Nano-materials; Perspectives and Possibilities in Nano-Medicine”, BME Handbook, 3rd Edition, Tissue Engineering and Artificial Organs Volume, Ch. 26, Taylor and Francis Group, Boca Raton, FL, (2006).Google Scholar